Top

Published in:

01-12-2019 | Case Report

Primary Angiosarcoma Pancreas: a Case Report of an Exceptional Localization

Authors: Tchin Darré, Mazamaesso Tchaou, Boyodi Tchangaï, Fousseni Alassani, Sassil Daré, Gado Napo-Koura

Published in: Journal of Gastrointestinal Cancer | Issue 4/2019

Excerpt

Pancreas sarcomas are very rare and represent less than 1% of all pancreas cancers [1]. Angiosarcoma is uncommon and has defavorable prognosis [1, 2]. The diagnosis of angiosarcoma is based on histological analysis and differentiated from aciae hemangiopericytoma and Kaposi’s sarcoma [3]. We reported a case of primary non-metastatic pancreas angiosarcoma in a 41-year-old man in Togo, confirmed by immunohistochemistry. We described epidemiological, morphological, and immunohistochemical aspects of primary pancreas angiosarcoma. …

Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010;11(10):983–91.CrossRef

Fayette J, Martin E, Piperno-Neumann S, le Cesne A, Robert C, Bonvalot S, et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol Ann Oncol. 2007;18(12):2030–6.CrossRef

Seth AK, Argani P, Campbell KA. Angiosarcoma of the pancreas: discussion of a rare epithelioid neoplasm. Pancreas. 2008;37(2):230–1.CrossRef

Kim JY, Song JS, Park H, Byun JH, Song KB, Kim KP, et al. Primary mesenchymal tumors of the pancreas: single-center experience over 16 years. Pancreas. 2014;43(6):959–68.CrossRef

Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 1998;22(6):683–97.CrossRef

Ferrozzi F, Zuccoli G, Bova D, Calculli L. Mesenchymal tumors of the pancreas: CT findings. J Comput Assist Tomogr. 2000;24(4):622–7.CrossRef

Ambe P, Kautz C, Shadouh S, Heggemann S, Köhler L. Primary sarcoma of the pancreas, a rare histopathological entity a case report with review of literature. World J Surg Oncol. 2011;9(3):85.CrossRef

ISSVA Classification of Vascular Anomalies. International Society for the Study of Vascular Anomalies, 2014. http//issva.org/classification. Accessed September 2016.

Csiszkó A, László I, Palatka K, Szabó KG, Kanyári Z, Bidiga L, et al. Primary angiosarcoma of the pancreas mimicking severe acute pancreatitis case report. Pancreatology. 2015;15(1):84–7.CrossRef

10.

Darré T, Amégbor K, Omorou M, et al. Contribution of immunohistochemistry in the diagnosis of angiosarcomas. J Afr Cancer. 2013;5:37–41.CrossRef

11.

Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15(4):434–40.CrossRef

12.

Huntington JT, Jones C, Liebner DA, Chen JL, Pollock RE. Angiosarcoma: a rare malignancy with protean clinical presentations. J Surg Oncol. 2015;111(8):941–50.CrossRef

13.

Anderson NJ, Boguslawski EB, Kuk CY, Chambers CM, Duesbery NS. Combined inhibition of MEK and mTOR has a synergy effect on angiosarcoma tumor grafts. Int J Oncol. 2015;47(1):71–80.CrossRef

14.

Salti GI, Ailabouni L, Undevia S. Cytoreductive surgery and hyperthermia intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis. Ann Surg Oncol. 2012;19(5):1410–5.CrossRef

15.

Sindhu S, Gimber LH, Cranmer L, McBride A, Kraft AS. Angiosarcoma treated successfully with anti-PD-1 therapy—a case report. J Immunother Cancer. 2017;5(1):58. https://doi.org/10.1186/s40425-017-0263-0.CrossRefPubMedPubMedCentral

Title: Primary Angiosarcoma Pancreas: a Case Report of an Exceptional Localization
Authors: Tchin Darré
Mazamaesso Tchaou
Boyodi Tchangaï
Fousseni Alassani
Sassil Daré
Gado Napo-Koura
Publication date: 01-12-2019
Publisher: Springer US
Published in: Journal of Gastrointestinal Cancer / Issue 4/2019
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-018-0123-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2019

Alpha-fetoprotein Secreting Neuroendocrine Carcinoma of the Liver: a Case Report and Literature Review

Pseudomyxoma Peritonei: Case Report and Literature Review

Testicular Choriocarcinoma Metastasizing to the Small Bowel Causing Intussusception: Case Report

Dose Escalation with Simultaneous Integrated Boost (SIB) Using Volumetric Modulated Arc Therapy (VMAT) in Rectal Cancer

Duodenal Invasion of Pancreatic Cancer Resulting in Hematemesis

A Modified Low-Cost Technique of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Two Patients: a Solution for Pseudomyxoma Peritonei in the Indian Scenario?

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials